PHI with Infantile eczema (treated and symptom-free)
How does this condition affect your private health insurance?
Ekzema infantum, or infantile eczema (atopic dermatitis), is a common chronic inflammatory skin condition primarily affecting infants. It typically presents as red, itchy, scaly patches, often on the face, scalp, and extensor surfaces. The designation "behandlungs- u. beschwerdefrei" (treatment- and symptom-free) indicates a mild form that resolves spontaneously without specific medical intervention or persistent discomfort. It's often associated with a genetic predisposition to atopy. While distressing for parents, many children outgrow this condition by early childhood, particularly those with this milder, self-limiting presentation, leading to a complete resolution of symptoms and no need for ongoing treatment.
PKV Risk Assessment
Impact on Your Insurance Policy
Duration of Illness (Initial)
Several days to a few weeks for initial flare-ups.
Duration of Illness (Lifetime)
Intermittent flares resolving completely by early childhood (typically before age 5).
Cost of Treatment (Initial)
Minimal; primarily over-the-counter emollients or mild moisturizers, if any.
Cost of Treatment (Lifetime)
Negligible to none, as the condition resolves without persistent issues.
Mortality Rate
Extremely low, virtually zero, directly from the disease itself.
Risk of Secondary Damages
Low; potential for minor skin irritation, but typically no significant physical or psychological long-term damage due to its mild, self-resolving nature.
Probability of Full Recovery
Very high (over 80-90%) for the 'behandlungs- u. beschwerdefrei' type, with most children fully outgrowing it.
Underlying Disease Risk
Moderate (20-50%) for developing other atopic conditions such as asthma or allergic rhinitis (hay fever) later in life, even if the eczema resolves.